- Supports drug discovery/development of academia originated technology
- Anticipates developing nucleic acid drugs that can be administered systemically and address unmet medical needs
- Contributes stimulation of drug-discovery/development venture industry through co-investment with private venture capitals
Our Portfolio
NapaJen Pharma, Inc.
| Outline | A Delivery technology platform of nucleic acids or other materials, and drug-development using the delivery platform |
|---|---|
| Website | |
| Industry | Health/medicine |
| Commercialization stage | Early stage |
Provided Support
| Authorized Investment | USD 9 million (maximum)／USD 12 million (maximum)／USD 12 million (maximum) |
|---|---|
| Announcement Date | February 3, 2014／December 7, 2016／December 25, 2018 |
| Investment Structure |